Results

Total Results: 3,357 records

Showing results for "aspirin".

281. USPSTF Seeks Comment on Its Draft Recommendation Statement on Low-Dose Aspirin for Women at High Risk for Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/asprpregdraftbulletin.pdf
     May 05, 2014 - USPSTF Seeks Comment on Its Draft Recommendation Statement on Low-Dose Aspirin for Women at High Risk … Preventive Services Task Force Seeks Comment on Its Draft Recommendation Statement on Low-Dose Aspirin … ) today posted a draft recommendation statement and published a final evidence summary on low-dose aspirin … The Task Force recommends low-dose aspirin (81 mg/day) use after 12 weeks of pregnancy in women who … and discuss if taking aspirin is right for them.”

282. U.S. Preventive Services Task Force Posts Draft Recommendation Statement on Aspirin Use for the Prevention of Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/aspirin-preeclampsia-prevention-draft-rec-bulletin.pdf
     March 22, 2021 - Preventive Services Task Force Posts Draft Recommendation Statement on Aspirin Use for the Prevention … Preventive Services Task Force Posts Draft Recommendation Statement on Aspirin Use for the Prevention … Preventive Services Task Force (Task Force) today posted a draft recommendation statement on aspirin … Based on the review of the evidence, the Task Force recommends the use of low-dose aspirin (81 mg/d … discuss if taking aspirin is right for them.”

283. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-aspirin-use-prevent-preeclampsia-and-related-morbidity-and-mortality
     September 28, 2021 - Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality … Preventive Services Task Force released today a final recommendation statement on aspirin use to prevent … The Task Force recommends low-dose aspirin for pregnant people at increased risk for preeclampsia.

284. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-review-aspirin-use-prevent-preeclampsia-and-related-morbidity-and
     March 22, 2021 - Public Comment on Draft Recommendation Statement and Draft Evidence Review: Aspirin Use to Prevent Preeclampsia … Services Task Force seeks comments on a draft recommendation statement and draft evidence review on aspirin … The Task Force recommends low-dose aspirin for pregnant people at increased risk.

285. USPSTF Aspirin Therapy for Primary Prevention of CVD and CRC (April 2021) (pdf file)
     cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
     April 01, 2021 - Suggested action: order aspirin. 3. … Evidence Source for Artifact Development The Aspirin Therapy artifact is derived from the Aspirin Use … Decision Log Artifact Semistructured Logic The Aspirin Therapy artifact is derived from the Aspirin … already receiving aspirin (at any dose), then a CDS recommendation to initiate low-dose aspirin therapy … Verify Completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual

286. U.S. Preventive Services Task Force Recommends Low-Dose Aspirin for Women at High Risk for Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/asprpregfinalrsbulletin.pdf
     September 09, 2014 - Preventive Services Task Force Recommends Low-Dose Aspirin for Women at High Risk for Preeclampsia … Preventive Services Task Force Recommends Low-Dose Aspirin for Women at High Risk for Preeclampsia … final recommendation statement recommending that women at high risk for preeclampsia use low-dose aspirin … For women at high risk, low-dose aspirin has been found to reduce the risk for preeclampsia by 24%, … level and discuss if taking aspirin is right for them.”

287. Screening for Skin Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cLuJZx55Z6ApzYv836rkSp
     February 23, 2009 - Screening for Skin Cancer ASPIRIN FOR THE PREVENTION OF CARDIOVASCULAR DISEASE CLINICAL SUMMARY … Men Age < 45 Years Women Age < 55 Years Men & Women Age ≥ 80 Years Encourage aspirin … potential CVD benefit (MIs prevented) outweighs potential harm of GI hemorrhage Encourage aspirin … As the potential CVD benefit increases above harms, the recommendation to take aspirin should become … to the risk with aspirin use alone.

288. Evaluation of the Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Events: A Comparison of Quantitative Approaches | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-balancing-harms-benefits/research
     November 01, 2017 - Home Evidence Reports Evaluation of the Benefits and Harms of Aspirin … Results The NNT and NNH for aspirin declined with increasing age because of the increase in baseline … for 10 years, compared with no aspirin use). … When we used relative weights, the Gail/NCI approach showed that aspirin caused more benefit than harm … When we weighted outcomes equally in a sensitivity analysis, the harm from aspirin was greater compared

289. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant (warfarin64), or a vasodilator (cilostazol67 … acid (aspirin); CV = cardiovascular 17 from the combination of omega-3 fatty acids plus niacin … acid 500 mg daily? … The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic … acid on platelet function and plasma lipids.

290. Dietary-Supplements Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant (warfarin64), or a vasodilator (cilostazol67 … acid (aspirin); CV = cardiovascular 17 from the combination of omega-3 fatty acids plus niacin … acid 500 mg daily? … The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic … acid on platelet function and plasma lipids.

291. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - One pragmatic trial in 19,934 women randomized to vitamin E plus aspirin versus aspirin alone for 10 … Ginkgo biloba Five RCTs investigated this supplement in combination with antiplatelet agents (acetylsalicylic … acid, clopidogrel, or ticlopidine), an anticoagulant (warfarin), or a vasodilator (cilostazol). … Ginkgo biloba Five RCTs investigated this supplement in combination with antiplatelet agents (acetylsalicylic … acid, clopidogrel, or ticlopidine), an anticoagulant (warfarin), or a vasodilator (cilostazol).

292. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - One pragmatic trial in 19,934 women randomized to vitamin E plus aspirin versus aspirin alone for 10 … Ginkgo biloba Five RCTs investigated this supplement in combination with antiplatelet agents (acetylsalicylic … acid, clopidogrel, or ticlopidine), an anticoagulant (warfarin), or a vasodilator (cilostazol). … Ginkgo biloba Five RCTs investigated this supplement in combination with antiplatelet agents (acetylsalicylic … acid, clopidogrel, or ticlopidine), an anticoagulant (warfarin), or a vasodilator (cilostazol).

293. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - Cardiovascular Harms of Non-Acetylsalicylic Acid (ASA) Nonsteroidal Anti-inflammatory Drugs (NSAIDs) … acid NSAIDs or acetylsalicylic acid plus non-acetylsalicylic acid NSAIDs. … Cardiovascular Harms of Non-Acetylsalicylic Acid (ASA) Nonsteroidal Anti-inflammatory Drugs (NSAIDs) … ASA = acetylsalicylic acid; FAP = familial adenomatous polyposis; IBD = inflammatory bowel disease; NR … ASA = acetylsalicylic acid; CRC = colorectal cancer; FOBT = fecal occult blood test; GMH = germinal matrix

294. AHRQ CDS TEP CDSC Updates - Dashboards Demonstration (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/2-2010_0201_TEP_Demos_Dashboards.pdf
     January 01, 2010 - Dashboard: CAD and no aspirin Dashboard: CAD and no aspirin Reminder: CAD and no aspirin %patients … 30 days Reminder: CAD and no aspirin Reminder: CAD and no aspirin (Coded acknowledgement responses … ) Reminder: CAD and no aspirin (Dec 2009) Reminder: CAD and no aspirin (Dec 2009) Reminder: … Reminder: CAD and no aspirin Reminder: CAD and no aspirin�(Coded acknowledgement responses) Reminder … : CAD and no aspirin (Dec 2009) Clinician’s Dashboard Lessons Learned (challenges) Future Plans

295. Intervention Tracking (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/intervention-tracking-worksheet-mw.pdf
     May 19, 2016 - POINT-OF-CARE CLINICAL DECISION SUPPORT* Reminder to order aspirin/antiplatelet drug for pts with … statin in general population with increased risk (based on a risk calculator) Reminder to order aspirin … REPORTS ON ABCS PERFORMANCE Metric for use of aspirin or another antithrombotic therapy in IVD … MANAGEMENT: LISTS OF PATIENTS NOT MEETING ABCS MEASURES List of patients with IVD not meeting aspirin … POPULATION MANAGEMENT: OUTREACH Outreach to patients with IVD not on aspirin or another antithrombotic

296. U.S. Preventive Services Task Force Publishes Final Recommendation Statement on Aspirin Use for the Prevention of Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/aspirin-preeclampsia-prevention-final-rec-bulletin.pdf
     September 28, 2021 - Preventive Services Task Force Publishes Final Recommendation Statement on Aspirin Use for the Prevention … Preventive Services Task Force Publishes Final Recommendation Statement on Aspirin Use for the Prevention … of Preeclampsia Task Force recommends low-dose aspirin for pregnant people at increased risk WASHINGTON … Preventive Services Task Force (Task Force) today published a final recommendation statement on aspirin … Based on the review of the evidence, the Task Force recommends the use of low-dose aspirin (81 mg/day

297. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
     September 29, 2021 - Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication An Update for This Topic is In … See Current Final Recommendation Statement for Aspirin Use to Prevent Cardiovascular Disease and Colorectal … Tools Related Resources Aspirin

298. Clinicians' reports in electronic health records versus patients' concerns in social media: a pilot study of adverse drug reactions of aspirin and atorvastatin. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/encoding-and-processing-patient-allergy-information-ehrs/citation/clinicians
     January 01, 2023 - health records versus patients' concerns in social media: a pilot study of adverse drug reactions of aspirin … health records versus patients' concerns in social media: a pilot study of adverse drug reactions of aspirin

299. Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
     February 17, 2021 - Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication An Update … See Current Final Recommendation Statement for Low-Dose Aspirin Use for the Prevention of Morbidity … Tools Related Resources Aspirin

300. Bleeding Risks Increase When Blood Thinners and Aspirin Are Taken Together | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/902.html
     February 01, 2024 - Bleeding Risks Increase When Blood Thinners and Aspirin Are Taken Together Issue Number 902 … Bleeding Risks Increase When Blood Thinners and Aspirin Are Taken Together Patients are at higher risk … of excessive bleeding when taking both blood thinners and aspirin together, according to an AHRQ-funded … patients who took both oral anticoagulant medications (which are blood thinners such as warfarin) and aspirin … in atrial fibrillation and for treatment and secondary prevention of venous thromboembolism, while aspirin